Ji Hyeon Ahn Selected Research

Ji Hyeon Ahn Research Topics

Disease

75	Ischemia 05/2022 - 03/2012
43	Transient Ischemic Attack 10/2019 - 03/2012
38	Brain Ischemia (Cerebral Ischemia) 09/2021 - 03/2012
19	Reperfusion Injury 04/2022 - 07/2013
13	Gliosis 01/2021 - 01/2013
12	Cognitive Dysfunction 01/2022 - 01/2016
9	Ischemic Stroke 01/2022 - 01/2013
9	Heart Arrest (Cardiac Arrest) 10/2021 - 09/2017
7	Hypothermia 12/2021 - 07/2019
6	Hyperthermia 01/2022 - 01/2015
6	Inflammation (Inflammations) 10/2021 - 12/2015
4	Brain Injuries (Brain Injury) 04/2022 - 01/2018
3	Spinal Cord Injuries (Spinal Cord Injury) 10/2021 - 01/2012
3	Hypoxia (Hypoxemia) 11/2017 - 09/2013
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017 - 08/2012
2	Epilepsy (Aura) 01/2022 - 10/2019
2	Paraplegia (Spastic Paraplegia) 10/2021 - 07/2019
2	Neuroinflammatory Diseases 10/2021 - 04/2020
2	Wounds and Injuries (Trauma) 01/2020 - 01/2014
2	Obesity 01/2019 - 12/2018
2	Body Weight (Weight, Body) 12/2018 - 09/2014
2	Lennox Gastaut Syndrome 04/2018 - 11/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2018 - 02/2017
2	Amnesia (Dissociative Amnesia) 04/2018 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 04/2018 - 01/2018
2	Seizures (Absence Seizure) 11/2017 - 09/2016
2	Stroke (Strokes) 01/2017 - 05/2013
2	Major Depressive Disorder (Major Depressive Disorders) 11/2016 - 11/2015
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2016 - 07/2014
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022

Drug/Important Bio-Agent (IBA)

37	Neuroprotective AgentsIBA 04/2022 - 10/2012
32	salicylhydroxamic acid (SHAM)IBA 01/2022 - 03/2013
26	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2012
19	AntioxidantsIBA 04/2022 - 05/2012
11	Glial Fibrillary Acidic ProteinIBA 05/2022 - 05/2013
11	CytokinesIBA 11/2021 - 06/2012
10	CalciumIBA 01/2020 - 05/2013
8	EnzymesIBA 04/2022 - 11/2015
8	fluoro jadeIBA 10/2019 - 09/2013
7	Superoxide DismutaseIBA 04/2022 - 01/2014
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2019 - 01/2014
6	Anticonvulsants (Antiepileptic Drugs)IBA 12/2021 - 12/2015
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 09/2015
6	CatalaseIBA 01/2020 - 06/2014
6	Glutathione PeroxidaseIBA 01/2020 - 06/2014
6	cresyl violetIBA 10/2019 - 01/2015
6	Scopolamine (Hyoscine)FDA Link 04/2018 - 08/2016
5	Interleukin-4 (Interleukin 4)IBA 10/2020 - 06/2012
4	Immunoglobulin G (IgG)IBA 01/2022 - 10/2020
4	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2021 - 06/2014
4	Interleukin-13IBA 10/2020 - 06/2012
4	Superoxide Dismutase-1IBA 01/2020 - 01/2014
4	MelatoninIBA 12/2018 - 06/2016
4	tanshinoneIBA 08/2016 - 09/2013
3	Oxcarbazepine (Trileptal)FDA LinkGeneric 12/2021 - 10/2019
3	Antipsychotic Agents (Antipsychotics)IBA 10/2021 - 06/2014
3	NMDA receptor A1IBA 01/2021 - 02/2013
3	Superoxides (Superoxide)IBA 11/2020 - 06/2014
3	Myelin Basic ProteinIBA 04/2018 - 01/2016
3	ThioredoxinsIBA 01/2017 - 05/2012
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2017 - 08/2012
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2016 - 11/2015
3	DiterpenesIBA 08/2016 - 12/2012
2	Therapeutic UsesIBA 01/2022 - 10/2021
2	Blood Proteins (Serum Proteins)IBA 11/2021 - 07/2017
2	AlbuminsIBA 11/2021 - 07/2017
2	Transcription Factors (Transcription Factor)IBA 07/2021 - 05/2013
2	Chlorogenic AcidIBA 03/2021 - 08/2020
2	Calbindin 1IBA 01/2021 - 06/2017
2	CollagenIBA 12/2020 - 03/2019
2	laminaranIBA 04/2020 - 01/2020
2	Voltage-Gated Sodium ChannelsIBA 04/2020 - 11/2017
2	Nerve Growth Factors (Neurotrophins)IBA 06/2019 - 01/2014
2	Insulin-Like Growth Factor I (IGF-1)IBA 06/2019 - 01/2014
2	Biological ProductsIBA 03/2019 - 10/2015
2	fucoidanIBA 01/2019 - 01/2019
2	CholesterolIBA 12/2018 - 09/2014
2	Blood Glucose (Blood Sugar)IBA 12/2018 - 09/2014
2	Triglycerides (Triacylglycerol)IBA 12/2018 - 09/2014
2	rufinamide FDA Link 04/2018 - 11/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 12/2014
2	Fenofibrate (CiL)FDA LinkGeneric 07/2017 - 02/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 02/2013
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2016 - 11/2015
2	Serotonin (5 Hydroxytryptamine)IBA 11/2016 - 11/2015
2	Lacosamide FDA Link 09/2016 - 12/2015
2	GlucokinaseIBA 10/2015 - 12/2013
2	glucokinase regulatory proteinIBA 10/2015 - 12/2013
2	InterleukinsIBA 09/2015 - 06/2012
2	Interleukin-2 (IL2)IBA 12/2014 - 06/2012
2	decursinIBA 01/2013 - 10/2012
1	astaxanthine (astaxanthin)IBA 04/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	stiripentolIBA 01/2022
1	Transient Receptor Potential ChannelsIBA 12/2021

Therapy/Procedure

5	Therapeutics 04/2021 - 09/2016
4	Induced Hypothermia 12/2021 - 07/2019
3	Transplantation 01/2018 - 01/2012
2	Cardiopulmonary Resuscitation (CPR) 10/2021 - 07/2019
2	Resuscitation 01/2020 - 01/2020